Sunshine Biopharma Inc (SBFM)

[PRED2020]

So the Great Dr. didn't invent this? Get's more interesting daily.
And Advanomics gave up a multi $BILLION dollar drug for $4.32 million +R&D of course. Why would they do that?



The company acquired U.S. patent 8,236,935 for Adva-27a in October for a total $4.32 million—12 consecutive annual payments of $360,000—from Advanomics, which at the time owned approximately 23% of Sunshine's issued and outstanding common stock. Sunshine had licensed the U.S. patent from Advanomics for an annual fee of $360,000, plus reimbursement of Advanomics’ R&D expenses, under an agreement that was ended once the U.S. patent changed hands.